Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Power Metal exits position in Guardian Metal for £14m

(Sharecast News) - Diversified mining company Power Metal Resources has sold its remaining stake in Guardian Metal Resources for £13.6m, marking an 11.8 times return on its original investment. Both stocks jumped more than 10% in early deals on Tuesday, with Power Metal up 10.7% at 15.5p and Guardian Metal up 11.3% at 64.56p.

Power Metal said on Tuesday it had entered into a legally binding sale and purchase agreement with an investment fund managed by the Duquesne Family Office to sell its 24.7m shares at a price of 55p each.

The disposal follows a £9.2m sale of Guardian Metal shares in February, which at the time left Power Metal with a 19.46% stake.

Guardian Metal, which first listed in AIM in 2023, has seen its share price more than double since the start of 2025, having risen by nearly 700% since its IPO.

Power Metal first invested £1.9m in Guardian Metal, but has now raised £22.8m from two separate disposals before costs.

"I am very pleased to be able to announce that we have agreed terms to exit our position in GMET after what has been an enormously successful investment for Power Metal, and one that has generated very considerable shareholder value," said Power Metal's chief executive Sean Wade.

"It represents a strong validation of our incubator model and gives us considerable firepower now to pursue other opportunities, a number of which have presented themselves to us in recent weeks," Wade said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.